Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A before repair of massive ventral hernia
ACTRN12624000701527Phase 4Recruiting
- Sponsor
- Dr Mary Ann Johnson
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abdominal hernia comparing Botulinum toxin type A with Normal saline placebo (2 arms). Primary endpoint: Hernia recurrence. Started Jun 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
abdominal hernia
Beyond the preview
Go deeper on ACTRN12624000701527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000701527.